Gut microbiota: next frontier in understanding human health and development of biotherapeutics - Test2 - elhamkhani - TriplyDB

Gut microbiota: next frontier in understanding human health and development of biotherapeutics

Gut microbiota: next frontier in understanding human health and development of biotherapeutics

http://www.wikidata.org/entity/Q24617327

about

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health Molecular characterization of novel pyridoxal-5′-phosphate-dependent enzymes from the human microbiome Immunomodulation of enteric neural function in irritable bowel syndrome Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity?Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN).Prostate cancer and the influence of dietary factors and supplements: a systematic review.Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome.Matrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis.Delayed accumulation of intestinal coliform bacteria enhances life span and stress resistance in Caenorhabditis elegans fed respiratory deficient E. coli.Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified Metaproteomics analysis reveals the adaptation process for the chicken gut microbiota.Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes.Differential induction of total IgE by two Salmonella enterica serotypes.Microbiota-mitochondria inter-talk: consequence for microbiota-host interaction.Sample storage conditions significantly influence faecal microbiome profiles.The gut microbiota and irritable bowel syndrome: friend or foe?Rationale for further medical and health research on high-potency sweeteners.Synbiotics and gastrointestinal function-related quality of life after elective colorectal cancer resection Systemic Concentrations of Short Chain Fatty Acids Are Elevated in Salmonellosis and Exacerbation of Familial Mediterranean Fever.Importance of gut microbiota in health and diseases of new born infants.Cocoa polyphenols and inflammatory markers of cardiovascular disease.The effect of hydrolysates of proteins from rice milk on the physiological response of enterocytes and on the adhesion of bacteria from healthy and allergic people - an in vitro study.The effect of age on the intestinal mucus thickness, microbiota composition and immunity in relation to sex in mice.Gut Microbiota: Association with NAFLD and Metabolic Disturbances.Emergency and Critical Care Medicine: An Essential Component of All Specialties and Practices.Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis.Inflammatory Bowel Disease: Complexity and Variability Need Integration.Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice.Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome.Role of Microbiota in Sexually Dimorphic Immunity.Sex and strain dependent differences in mucosal immunology and microbiota composition in mice.Impact of violacein from Chromobacterium violaceum on the mammalian gut microbiome

P2860

Q26738283-AEDF2C7D-7EEB-44AF-B8CB-E4950184E63B Q27684034-B7400443-596D-4CC9-9756-6951C0B465DA Q28086910-E71738C9-1A3A-4638-A155-E19CB062BE3C Q29011203-C6E893B5-62FD-45AE-8EC3-E1E0FD10C029 Q30235155-1530E956-01E1-4E4F-B5AB-4063BBE45821 Q33746322-E7016AE2-A2AD-495F-AC35-11377537BADA Q33748498-2AEF0B5C-A0A2-45E1-851A-32B0785F51EB Q33813910-331032DA-BC7D-4B35-A458-E9C7B65A1E09 Q33958801-FCBDDA16-DC1B-4F77-946E-EBB460F1982E Q34255464-53E284AF-1347-4143-8CDC-CCDD453AF6EE Q34302957-302D4281-4EB5-423D-8D5F-106B907E3BAB Q34519045-CF95A2C9-AF10-4C3D-8FF9-3E80FBF61DC0 Q34629039-605CA2D0-828C-4CE8-B8F1-6F0450494653 Q35018672-35E4E3C7-0D53-49D6-BAC4-49C331C5AE4B Q35037994-27FAD794-67D7-4A1B-94F5-524939DC3E5C Q35483922-6A2C6C74-9AD8-477A-A3B6-BA7B7AD433A3 Q35646842-B8E3B613-762E-4347-B1A3-7C9D1C2A01B9 Q35820966-8E1732D7-5087-448D-AD16-093ABC59F956 Q35842738-704729B5-FFDD-400B-90FC-EF31529679DD Q35942511-B503C350-7C5E-4D67-9693-6BD91B235D68 Q36231086-C6BC5AAA-0A0E-4E01-A0D7-3A90D458B5E2 Q36429116-B4BBC092-86B0-4B49-8259-127C297805AF Q36927947-725161CF-79CC-41AE-A03A-A608E5C8C37A Q37001049-7C81A67D-97A6-4F7E-9148-741040655D2D Q37617758-2162FAD1-CAAE-4FD1-BDDE-4C6C7CCB6DA4 Q37739802-1BE69A23-DBFD-4CCC-8BEF-BEA56BE93E52 Q41228102-7E39216F-A37F-4501-A132-A0DC50B3A535 Q41564230-6FF1C615-BCD1-426E-B790-FD0FDB5386AD Q42699603-9057891C-FEC9-43B1-A363-66C02E1CF4CF Q44399817-7928ABC3-742C-412B-9FA3-CBEF6BDAE0E7 Q52331504-6648A56A-235C-4A26-AE7C-7C45F7728D40 Q53099275-A74BDD29-F503-466F-809F-D21B3AD4A994 Q55267340-7FBAC04D-7DB3-4DA8-944C-B9540404FDFE Q55313206-B61DA102-D9A2-4779-91D7-BF9025FA6531 Q55340807-C9F7AAA4-265E-40E9-847D-5076B9F99EC0 Q58744382-B85C355D-8213-48F7-85FA-81BA7F8F0CA1

P2860

Gut microbiota: next frontier in understanding human health and development of biotherapeutics

http://www.wikidata.org/entity/Q24617327

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Gut microbiota: next frontier ...... development of biotherapeutics

@ast

Gut microbiota: next frontier ...... development of biotherapeutics

@en

Gut microbiota: next frontier ...... development of biotherapeutics

@nl

type

label

Gut microbiota: next frontier ...... development of biotherapeutics

@ast

Gut microbiota: next frontier ...... development of biotherapeutics

@en

Gut microbiota: next frontier ...... development of biotherapeutics

@nl

prefLabel

Gut microbiota: next frontier ...... development of biotherapeutics

@ast

Gut microbiota: next frontier ...... development of biotherapeutics

@en

Gut microbiota: next frontier ...... development of biotherapeutics

@nl

P1433

Q24617327-7A9185FE-34CF-4B98-BF17-4FEC8C0EF0B5

P1476

Q24617327-1A59B343-0850-4F3B-971E-15D57739083D

P2093

Q24617327-416F1BF6-BBAB-4BFA-BC34-834921A3B283

Q24617327-87AEBFDD-9C1C-4F8A-980D-84D46796F2AA

Q24617327-ED446B1C-E4B7-42EB-8A53-47A26A8C357C

Q24617327-F2E476DE-2066-4195-9C44-13AB5B7E1F55

P2860

Q24617327-04328DD4-D953-412F-97BD-F29DA51FD1A9

Q24617327-081718B7-EB82-4D3D-AA88-433F4E0FF648

Q24617327-0BDC87B5-CB5B-42EB-A8C3-DABE545FC52B

Q24617327-0FE8DD15-0254-4404-A12F-D22FBE825CE8

Q24617327-103FA886-FAA2-432F-946A-EA47A68DEE3A

Q24617327-1A0646A0-AF43-44F9-A99E-65939C0B3F60

Q24617327-1A4AB0B4-3467-4420-95EB-2DDB47B4EA62

Q24617327-1F5363E8-308D-4B42-BEA8-DBB7C65D4D0C

Q24617327-23C684EA-E9BF-4F2F-940F-B9C22FEBAAF5

Q24617327-2548D8E0-9E86-4622-B7D4-1DC60A7FC449

P304

Q24617327-D9CD58D9-F1FF-4C2E-9C05-F5E25F31D697

P31

Q24617327-6C55B2C8-D8A5-4CBB-AD61-6C33595A7CFC

P3181

Q24617327-AAA0C3C0-DE3D-4C68-AD11-54166E383B13

P356

Q24617327-18EFFC79-7A3A-41A9-B693-57B4BA407B08

P407

Q24617327-767640DB-98D7-4CA5-BCA5-D78212E4D1E7

P478

Q24617327-BD42A909-B896-4DAF-AD10-913216FF7561

P577

Q24617327-14AEDB52-43D0-409C-9613-4A6E7B25620C

P698

Q24617327-841FCE73-E201-49EC-991C-6A59E06CA2BB

P932

Q24617327-FDCF3E23-4B74-4FC1-81D6-AD57EE1F2E21

P3181

P356

P1433

Biologics: Targets and Therapy

P1476

Gut microbiota: next frontier ...... development of biotherapeutics

@en

P2093

Catherine Tomaro-Duchesneau

http://www.w3.org/2001/XMLSchema#string

Laetitia Rodes

http://www.w3.org/2001/XMLSchema#string

Michael Coussa-Charley

http://www.w3.org/2001/XMLSchema#string

Satya Prakash

http://www.w3.org/2001/XMLSchema#string

P2860

Investigation of microencapsulated BSH active lactobacillus in the simulated human GI tract

Microbial Ecology of the Gastrointestinal Tract

Obesity alters gut microbial ecology

A human gut microbial gene catalogue established by metagenomic sequencing

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

Metagenomic analysis of the human distal gut microbiome

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

A core gut microbiome in obese and lean twins

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria.

P304

71-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1392543

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/BTT.S19099

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21847343

http://www.w3.org/2001/XMLSchema#string

P932

3156250

http://www.w3.org/2001/XMLSchema#string